Biomedical subjects

K Lauslahti

Publications and source records attributed to K Lauslahti.

34 records · Page 2Linked to original sources

PubMed1977

The effect of various doses of oral oestradiolvalerate and oestriolsuccinate on urine calcium/creatinine, serum FSH and endometrium in castrated women.

The effects of various doses recommended for clinical use of oestradiolvalerate and oestriolsuccinate on urine calcium/creatinine, serum FSH and endometrium were investigated in two castrated women. Oestrogen treatments were given in 6-week periods separated by 2 weeks without treatment. After various oestrogen treatments, serum FSH generally decreased clearly and urine calcium/creatinine slightly. The proliferative effect on endometrium was investigated histologically. In no period was a hyperplastic endometrium found.

Adult↗

PubMed1976

Screening for breast cancer in women aged 41--60.

All women aged 41--60 (20 644) living in the city of Tampere were invited to attend screening for breast cancer during the period April 1974--March 1975. The breasts and the axillary lymph nodes were examined and palpated by specially trained nurses. The women were instructed in self-examination and given a leaflet for study at home. If anything abnormal was revealed at this stage the subject was referred to a physician for further examination. The women who attended totalled 17 261 (84%), 627 (3.6%) of whom were referred for further examination and 615 attended. Surgical biopsy was recommended for 117 (19%) of these 615. Breast cancer was histologically verified in 27 subjects. Ten further cases of breast cancer were detected outside this screening during the same one year screening period, which made the overall detection rate 1.79 per thousand in this age group. As the expected incidence was 1.20 per thousand, the primary detection excess was 0.59 per thousand or 12 cases. A further advantage of screening of this kind is the instruction given to the subjects, which is expected to result in more cases of cancer being revealed at an earlier stage.

Adult↗

PubMed1975

Steroid binding properties of estradiol receptors in human breast cancer.

The incidence of a specific estradiol receptor among the Finnish breast cancer patients was investigated using methods involving dextran-coated charcoal or sucrose density gradient centrifugation techniques. An estradiol receptor was detected in 20 (71%) out of the 28 tumor specimens studied with the following binding site concentrations: 100-1000 fmoles/mg cytosol protein in 12 patients; 10-99 fmoles/mg cytosol protein in 6 patients and below 10 fmoles/mg cytosol protein in 2 patients the lowest detectable level being about 5 fmoles/mg cytosol protein. The apparent intrinsic association constant of the receptor for estradiol-17 beta ranged from 0.4-32 X 10(10) liters/mole in different breast cancer specimens. Estradiol receptor concentration did not seem to correlate well with the age of the patients or the microscopic structure of the tumor. The ligand-binding specificity of the receptor was studied with 25 different estrogen derivatives in 6 separate tumor specimens. The binding proteins in all these tumors showed very similar ligand specificities, despite differences in their histological types and estradiol-binding site concentrations. The phenolic hydroxyl group at C--3 was essential for an effective binding by the receptor, whereas certain modifications in the D-ring structure were well tolerated. As is the case with other steroid receptors, certain hydrophobic substituents seemed to increase the binding of the ligand by the breast cancer estradiol receptor. The in vitro binding affinity and the in vivo biological (estrogenic) potency of some of the steroids investigated did not correlate very well.

Adsorption↗

PubMed1974